This company listing is no longer active
Oncodesign Société Anonyme Management
Management criteria checks 1/4
Key information
Philippe Genne
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.6yrs |
| CEO ownership | n/a |
| Management average tenure | 8.6yrs |
| Board average tenure | no data |
Recent management updates
CEO
Philippe Genne
12.6yrs
Tenure
€204,420
Compensation
Dr. Philippe Genne, Ph D., Founded Oncodesign Société Anonyme, serves as its Chairman of the Board and has been its Chief Executive Officer since May 18, 2010 and Chief Corporate Business Development Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.6yrs | €204.42k | no data | |
| Chief Financial & Administrative Officer | 4.7yrs | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Deputy Managing Director | no data | €24.34k | no data | |
| Member of Executive Board | 14.9yrs | no data | no data | |
| Member of Executive Board | 14.9yrs | no data | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Chief Information Officer & Head of Artificial Intelligence | 2.3yrs | no data | no data | |
| Chief Legal Officer | no data | no data | no data | |
| Chief Human Resources Officer | no data | no data | no data |
8.6yrs
Average Tenure
52yo
Average Age
Experienced Management: ALONC's management team is seasoned and experienced (8.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/12/23 12:28 |
| End of Day Share Price | 2022/12/08 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oncodesign Société Anonyme is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gary Waanders | Bryan Garnier & Co |
| Victor Floch | Bryan Garnier & Co |
| Fanny Meindre | CIC Market Solutions (ESN) |